Results 91 to 100 of about 3,309 (140)

Patterns of medication use among individuals with Covid-19 in Brazil: Epicovid 2.0. [PDF]

Rev Saude Publica
Buffarini R, Victora CG, Hallal PC, Silveira MFD.   +3 more
europepmc   +1 more source

[Reply to: Ivermectin in COVID-19. Argumentum ad ignorantiam?] [PDF]

Rev Clin Esp, 2020
López Reboiro ML, Sardiña González C, López Castro J.   +2 more
europepmc   +2 more sources

[Case report of human myiasis caused by Cochliomyia hominivorax in Mexico]. [PDF]

Rev Med Inst Mex Seguro Soc
Hernández-Peláez DK, De la Mora-López CF, Vega-Dovalí M.   +2 more
europepmc   +1 more source

Antiviral and Anti-Inflammatory Properties of Ivermectin and Its Potential Use in COVID-19. [PDF]

Arch Bronconeumol, 2020
Portmann-Baracco A, Bryce-Alberti M, Accinelli RA.   +2 more
europepmc   +1 more source

[Bias Possibility in a Retrospective Study of Ivermectin for COVID-19]. [PDF]

Arch Bronconeumol, 2021
Meneses G, Ortega-Guillén E.
europepmc   +1 more source

Effect of ivermectin on Toxocara canis larvae in vitro and in vivo at different migratory stages [PDF]

Biomedica
Abou-El-Naga IF, El-Nassery SMF, El-Temsahy MM.   +2 more
europepmc   +1 more source

[Ivermectin in COVID-19. Argumentun ad ignorantiam?] [PDF]

Rev Clin Esp, 2020
Carlosama-Rosero Y.
europepmc   +2 more sources

[Furuncular lesions in a traveler returning from Senegal]. [PDF]

Aten Primaria
Cerpa Almenara V, Nebreda Mayoral T, Polo García C.   +2 more
europepmc   +1 more source

Case report: C57BL/6NTac and C57BL/6NCrl mice displaying neurological signs after deworming with ivermectin. [PDF]

Lab Anim
Eriksson M, Nylén S.
europepmc   +1 more source

Clinical presentation of scabies from 1996 to 2022: a retrospective cohort study from Finland. [PDF]

Scand J Prim Health Care
Mikola A, Jokela E, Jokelainen J, Kiviniemi E, Sinikumpu SP, Huilaja L.   +5 more
europepmc   +1 more source